Trading Window

Ref: 01/SE/LC/2026-27 Date: October 23, 2026 To, To, National Stock Exchange of India Limited BSE Limited (“BSE”) (“NSE”) Listing Department Listing Department Corporate Relationship Department Exchange Plaza, C-1 Block G, Bandra Kurla Phiroze Jeejeebhoy Towers, Complex Bandra (East), Mumbai – 400051 Dalal Street, Fort, Mumbai - 400 001 NSE Scrip Symbol: SMT BSE Scrip Code: 545001 ISIN: INE356Y01018 ISIN: INE356Y01018 Subject: Intimation of Closure of Trading Window Dear Sir/Madam, This is to inform you that pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, read with the Code of Conduct for Prohibition of Insider Trading as adopted by Sahajanand Medical Technologies Limited (“Company”), the Trading Window for dealing in Securities of the Company shall remain closed with effect from October 23, 2026 and shall reopen after 48 hours from the declaration of the Un-Audited (Standalone and Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2026 (“Financial Results”). The date of the Board Meeting to consider and approve the aforesaid Financial Results will be intimated in due course of time. Accordingly, all the Designated Persons, their immediate relatives and connected person of the Company are advised not to deal in the Equity Shares of the Company during the aforesaid period. We request you to kindly take the same on record. Thanking you, For Sahajanand Medical Technologies Limited Bhargav Dhirajlal Kotadia Managing Director & Chief Executive Officer DIN: 06575042